Clinical News: Page 40

Dosimetry key in Lu-177 cancer therapy

Personalized medicine is rapidly evolving in cancer theranostics, with technology now available that allows clinicians to optimize doses of radiopharmaceuticals on an individual patient level, according to experts.

February 5, 2025

Kesner Zanzonico

COVID-19 boosts cardiovascular event risk

By Kate Madden Yee

COVID-19 is associated not only with acute lung damage but also with rapid growth of plaque in the coronary arteries -- and thus an increased risk of cardiovascular events.

February 4, 2025

Using AI with mammography can help select women for breast MRI

By Amerigo Allegretto

Using AI with mammography can help select women at high risk of breast cancer for supplemental MRI.

February 4, 2025

Images depict a 55-year-old woman with a family history of breast cancer who underwent combined mammography and MRI screening. (A) Right and (B) left mediolateral oblique and (C) right and (D) left craniocaudal mammograms show a large known cyst in the left breast (arrow in B and D), but were otherwise assessed as being unremarkable. Breast tissue was judged to be extremely dense. (E) Concurrent axial subtraction MRI scan shows a large, diffuse, invasive lobular cancer (circle) in the right breast. The AI system provided a case-based cancer suspicion score of 8 on a scale of 0-10, which would have led to selection for MRI screening using both the score 5 and score 8 thresholds, but not the score 9 threshold.

Hot shots from Dubai: Arab Health picture gallery

Over 60,000 delegates attended the 50th edition of Arab Health Med Expo and the 25th edition of Total Radiology, held in Dubai from January 27 to 30. To mark the occasion, we've compiled a photo gallery.

February 3, 2025

Arab Health 2025 Sustainability

Ultrasound, histopathological diagnoses assess benign breast lesions

By Amerigo Allegretto

Sonographic imaging descriptors and histopathological diagnoses are needed for more accurate assessment of benign breast lesions.

February 3, 2025

Ultrasound Breast 400

Ablation underused to treat pain in cancer patients

Less than one percent of hospitalized cancer patients undergo percutaneous ablation to relieve pain associated with bone or soft tissue tumors.

February 3, 2025

IMV: MRI exam mix shifts from outpatient to hospital settings

By Davin Korstjens

In 2024, the percentage of MRI procedures performed in an outpatient setting decreased by five percentage points to 66% of total MR procedures.

February 3, 2025

Mri Machine Screens

AI assistance improves CHD detection on prenatal ultrasound

By Amerigo Allegretto

AI boosts detection of major congenital heart defects (CHDs) on prenatal ultrasound, suggest findings presented at the Annual Pregnancy Meeting of the SMFM.

January 31, 2025

Smfm Ultrasound Ai Fetal Thumbnail

LLM performance varies based on language input

Baidu’s AI chatbot Ernie Bot outperformed OpenAI’s ChatGPT-4.0 on interventional radiology questions in Chinese.

January 31, 2025

PET/CT guides surgery for primary aldosteronism

PET/CT imaging with gallium-68 pentixafor can effectively guide surgery for patients with primary aldosteronism, a common cause of hypertension.

January 30, 2025

Apa 679bd41fd4afc Thumbnail

Ferumoxytol-enhanced MRA is safe for chronic kidney disease patients

By Kate Madden Yee

Ferumoxytol-enhanced MR angiography (MRA) appears to be safe for chronic kidney disease patients, researchers have reported.

January 29, 2025

Contrast Injector

Ultrafast MRI exam bests standard MRI for classifying breast cancers

By Amerigo Allegretto

An ultrafast MRI-based radiomics exam performs just as well as standard MRI and isn’t dependent on radiologist experience.

January 28, 2025

Ultrafast and standard MRI in a 30-year-old woman with triple-negative invasive ductal carcinoma. (A) Ultrafast MRI taken 16.8 seconds after contrast agent injection. (B) Standard MRI taken 58.8 seconds after contrast agent injection. Both images show an oval-shaped, irregular marginated, rim-enhancing mass in the left outer breast. For 3D tumor segmentation, the entire enhanced tumor margins were drawn from top to bottom of each tumor in axial views of U2 phase postcontrast ultrafast MRI and the initial phase postcontrast standard MRI. Among the 14 ultrafast images, U1 is the first phase in which the signal intensity of the hotspot region of interest of the tumor is 10% higher than the average signal intensity of unenhanced images. U2 is the immediate next phase of U1 and the well-established tumor enhancement time.

Page 40 of 3660